Office-Use Orders (503B): You may either use our portal (see link above), send a fax to (832) 678-4419, call in a prescription at (346) 229-5385, or email your order to [email protected]
A phase 1 study to assess the safety, pharmacokinetics, and anti-tumor activity of the androgen receptor N-terminal domain inhibitor epi-506 in patients with metastatic castration-resistant prostate cancer
GLP-1s look promising for substance use disorders, but we dont yet know how effective they might be
For most conditions, a course of 46 sessions spaced weekly gives visible, sustained results
Its not recommended unless you're highly experienced and under guidance
Limitations of the Current Evidence Base No scientific review is complete without transparent discussion of what evidence can and cannot answer: Thyroid cancer is rare